This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
MorphoSys Yönetim
Yönetim kriter kontrolleri 1/4
We currently do not have sufficient information about the CEO.
Anahtar bilgiler
Arkadius Pichota
İcra Kurulu Başkanı
n/a
Toplam tazminat
CEO maaş yüzdesi | n/a |
CEO görev süresi | less than a year |
CEO sahipliği | n/a |
Yönetim ortalama görev süresi | less than a year |
Yönetim Kurulu ortalama görev süresi | 6.5yrs |
Son yönetim güncellemeleri
Recent updates
MorphoSys: Hold Rating Until The Novartis Deal Closes
May 01Novartis And MorphoSys Are A Perfect Match
Feb 06MorphoSys: Positive Pelabresib Data Finally Unlocking Upside
Jan 18MorphoSys updates Q2 & FY22 guidance below prior provided levels
Jul 26MorphoSys May Not Recover From Adventurous Constellation Buyout
May 04Sierra Oncology's Strong Data In Myelofibrosis Challenges MorphoSys And Incyte
Jan 28Incyte and MorphoSys presents new three-year data for blood cancer therapy
Jun 04MorphoSys reports Q1 results
May 05MorphoSys AG appoints Sangamo 's Sung Lee as new CFO
Jan 06MorphoSys AG (MOR) Investor Presentation - Slideshow
Dec 08MorphoSys AG 2020 Q3 - Results - Earnings Call Presentation
Nov 22MorphoSys reports Q3 results
Nov 11CEO
Arkadius Pichota
less than a year
Görev süresi
Mr. Arkadius Pichota, Ph D., MBA., is Chief Executive Officer of MorphoSys AG from June 2024. Mr. Pichota served as President, General Manager and Chairman of the Board of the Novartis subsidiary Navigate...
Liderlik Ekibi
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
Chief Legal and Human Resources Officer & Member of Management Board | 4.6yrs | €1.10m | 0.0036% $ 99.7k | |
Chief Executive Officer | less than a year | Veri yok | Veri yok | |
Chief Financial Officer | less than a year | Veri yok | Veri yok | |
Chief Research & Development Officer | 1.8yrs | Veri yok | Veri yok | |
Head of Accounting & Tax | no data | Veri yok | Veri yok | |
Head of Discovery Alliances & Technologies | no data | Veri yok | Veri yok | |
Head of Investor Relations | no data | Veri yok | Veri yok | |
Chief Business Officer | no data | Veri yok | Veri yok | |
Head of Technical Operations | no data | Veri yok | Veri yok | |
Head of Alliance Management | no data | Veri yok | Veri yok | |
Head of Clinical Operations | no data | Veri yok | Veri yok | |
Head of Business Team | no data | Veri yok | Veri yok |
1.0yrs
Ortalama Görev Süresi
Deneyimli Yönetim: MOR's management team is not considered experienced ( 1 years average tenure), which suggests a new team.
Yönetim Kurulu Üyeleri
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
Member of Scientific Advisory Board | 7.9yrs | Veri yok | Veri yok | |
Member of Scientific Advisory Board | 7.9yrs | Veri yok | Veri yok | |
Member of Scientific Advisory Board | 7.9yrs | Veri yok | Veri yok | |
Member of Scientific Advisory Board | 7.9yrs | Veri yok | Veri yok | |
Independent Member of Supervisory Board | 5.2yrs | €92.60k | Veri yok | |
Chairman of the Supervisory Board | less than a year | Veri yok | Veri yok | |
Member of the Supervisory Board | less than a year | Veri yok | Veri yok | |
Deputy Chairman of the Supervisory Board | less than a year | Veri yok | Veri yok |
6.5yrs
Ortalama Görev Süresi
51yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: MOR's board of directors are considered experienced (6.5 years average tenure).